Last Updated : April 15, 2025
Details
| Call for patient/clinician input open | March 12, 2024 |
|---|---|
| Call for patient/clinician input closed | May 07, 2024 |
| Submission received | April 19, 2024 |
| Submission accepted | May 06, 2024 |
| Review initiated | May 07, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | July 22, 2024 |
| Deadline for sponsors comments | July 31, 2024 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | August 29, 2024 |
| Expert committee meeting (initial) | September 11, 2024 |
| Draft recommendation issued to sponsor | September 25, 2024 |
| Draft recommendation posted for stakeholder feedback | October 03, 2024 |
| End of feedback period | October 18, 2024 |
| Final recommendation issued to sponsor and drug plans | October 31, 2024 |
| Final recommendation posted | November 19, 2024 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | November 15, 2024 |
| CDA-AMC review report(s) posted | April 09, 2025 |